GlycoMimetics lowers size of IPO


GlycoMimetics (GLYC) has cut the proposed size of its Nasdaq IPO to $46M from a previous plan of $56-64M and lowered the offer price to $8 a share from $14-16.

However, the biotech, which develops treatments for sickle cell episodes and acute myeloid leukemia (AML), has increased the number of shares it intends to sell to 5.8M from 4M. (S-1)

ETF: IPO

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs